BBIO News
BridgeBio Pharma, Inc.
$80.46
+$0.92(+1.16%)
55
Overall
40
Value
75
Tech
52
Quality
Market Cap
$15.67B
Volume
342.61K
52W Range
$62.06 - $93.42
Target Price
$106.86
BBIO news: the latest BridgeBio Pharma, Inc. headlines, press releases and market updates, newest first.
Latest BBIO News
- Barclays Keeps Their Buy Rating on BridgeBio Pharma (BBIO)TipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- BridgeBio’s Preferred Stock Structure Puts Common Shareholders at Risk of Subordination, Dilution, and Governance UncertaintyTipRanks Auto-Generated Newsdesk · Oct 31, 2026
- Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Fortrea Holdings Inc. (FTRE) and BridgeBio Pharma (BBIO)TipRanks Newsroom · Oct 30, 2026
- BridgeBio Pharma (BBIO) Gets a Buy from Piper SandlerTipRanks Auto-Generated Intelligence Newsdesk · Oct 30, 2026
- BridgeBio Pharma (BBIO) Receives a Buy from Bank of America SecuritiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 19, 2026
- BridgeBio Pharma (BBIO) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $80.46 | +1.2% | 342.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |